BST — Biotechnology Assets SA Share News
0.000.00%
Last trade - 00:00- €13.87m
- €14.78m
- €3.09m
Brief: Bionaturis gets license agreement for BNT005 vaccine in Argentina and Paraguay
Brief: Bionaturis unit gets patent in the United States
Brief: Bionaturis unit gets patents in Europe and Japan
Brief: Bionaturis gets patent in US for formulations of protein administration
Brief: Bionaturis gets 267,360 euro grant for animal vaccination project
Brief: Bionaturis gets incentive for vaccine development project
Brief: Bionaturis H1 loss before tax narrows to 16,000 euros
Brief: Bionaturis signs letter of intent with Labiana Life Sciences
Brief: Bionaturis to issue 457,143 shares to offset credits
Brief: Bionaturis buys Zera Intein Protein Solutions for 1.6 mln euros
Brief: Bionaturis FY 2015 net loss at 164,000 euros
Brief: Bionaturis Group signs deal with US National Institute of Health
Brief: Bionaturis takes part in development of vaccine against cervical cancer
Brief: Bionaturis in consortium to develop biopharmaceuticals
Brief: Bionaturis signs deal with US's environmental health institute
Brief: Bionaturis receives EU grant to develop cervical cancer vaccines
Brief: Bionaturis cancels share capital increase announced on May 22
Brief: Bionaturis signs intention letter with Inveready to buy its unit
Brief: Bionaturis unveils the development of six new biotech products